Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Be between 18 and 80 years old
- Be in good enough general health to be reasonably active (confirm with trial site what this means for your situation)
- Have been identified as being at nutritional risk based on a standard screening tool score (confirm with trial site)
- Have been diagnosed with malnutrition using a recognised assessment method
- Have been confirmed by tissue biopsy to have squamous cell cancer of the esophagus (food pipe)
- Have the cancer located in the chest portion of the esophagus
- Have a cancer stage that doctors consider suitable for surgery, assessed as stage II to IVA by a specialist team
- Be planned to receive treatment before surgery, such as chemotherapy, radiotherapy, or immunotherapy (or a combination of these)
- Be willing to give informed consent and follow the study plan
Who may not be able to join:
- Those who do not meet the nutritional risk score threshold
- Those planned to go straight to surgery without any treatment beforehand
- Those with any health condition that would affect their ability to digest or absorb the study nutritional supplement (ORAL IMPACT®)
- Those already receiving any other nutritional support during the study period
- Those unable to eat by mouth or receive nutrition through a feeding tube before surgery
- Those who have had another cancer in the past 5 years, except certain treated skin cancers or early cervical conditions
- Those with significantly abnormal liver or kidney function test results (confirm specific values with trial site)
- Those with uncontrolled diabetes, very high blood sugar, or untreated thyroid problems
- Those currently taking certain medications including omega-3 fat supplements, glutamine, specific hormones, steroids, or certain biologic medicines (confirm full list with trial site)
- Those with a known allergy to any ingredient in the study nutritional supplement (ORAL IMPACT®)
- Women who are pregnant, breastfeeding, or of childbearing age who are not using reliable contraception or have a positive pregnancy test
- Those unwilling or unable to sign the consent form or follow the study requirements
- Those considered unsuitable by the study doctors for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yin Li, M.D., Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phone: +86 13910052790
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of postoperative pulmonary complications; Rate of unplanned hospital admissions; Rate of unplanned ICU admission; Overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.